Phase II, Multicenter, Randomized Trial of Docetaxel plus Prednisone with or Without Cediranib in Men with Chemotherapy-Naive Metastatic Castrate-Resistant Prostate Cancer
一项多中心、随机、II期临床试验,比较多西他赛联合泼尼松加或不加西地尼布治疗既往未接受过化疗的转移性去势抵抗性前列腺癌男性患者的疗效
期刊:Oncologist
影响因子:4.2
doi:10.1634/theoncologist.2019-0331
Heath, Elisabeth; Heilbrun, Lance; Mannuel, Heather; Liu, Glenn; Lara, Primo; Monk, J Paul; Flaig, Thomas; Zurita, Amado; Mack, Philip; Vaishampayan, Ulka; Stella, Philip; Smith, Daryn; Bolton, Susan; Hussain, Arif; Al-Janadi, Anas; Silbiger, Daniel; Usman, Muhammad; Ivy, S Percy